Showing results (111-120 of 172) with videos related to

Sort By:
Pageof 18
Cancer Cell|September 6, 2007
FGFR3 activates RSK2 to mediate hematopoietic transformation through tyrosine phosphorylation of RSK2 and activation of the MEK/ERK pathwaySumin Kang, Shaozhong Dong, Ting-Lei Gu, et al.
Blood|December 17, 2008
High-throughput sequencing screen reveals novel, transforming RAS mutations in myeloid leukemia patientsJeffrey W Tyner, Heidi Erickson, Michael W N Deininger, et al.
American Journal of Hematology|June 18, 2011
Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotypeStephen M Wiesner, Jennifer L Geurts, Miechaleen D Diers, et al.
Blood|July 21, 2005
The small molecule tyrosine kinase inhibitor AMN107 inhibits TEL-PDGFRbeta and FIP1L1-PDGFRalpha in vitro and in vivoElizabeth H Stover, Jing Chen, Benjamin H Lee, et al.
Immunity|April 13, 2022
The interferon-stimulated gene RIPK1 regulates cancer cell intrinsic and extrinsic resistance to immune checkpoint blockadeLisa Cucolo, Qingzhou Chen, Jingya Qiu, et al.
Blood|August 30, 2011
Coordinate loss of a microRNA and protein-coding gene cooperate in the pathogenesis of 5q- syndromeMadhu S Kumar, Anupama Narla, Atsushi Nonami, et al.
Molecular Cancer Therapeutics|May 24, 2013
Preclinical evaluation of the WEE1 inhibitor MK-1775 as single-agent anticancer therapyAmy D Guertin, Jing Li, Yaping Liu, et al.
Cancer Cell|October 16, 2007
FLT3 mutations confer enhanced proliferation and survival properties to multipotent progenitors in a murine model of chronic myelomonocytic leukemiaBenjamin H Lee, Zuzana Tothova, Ross L Levine, et al.
Blood|July 19, 2011
Differential niche and Wnt requirements during acute myeloid leukemia progressionSteven W Lane, Yingzi J Wang, Cristina Lo Celso, et al.
Haematologica|May 25, 2010
Cdx4 is dispensable for murine adult hematopoietic stem cells but promotes MLL-AF9-mediated leukemogenesisSumin Koo, Brian J Huntly, Yuan Wang, et al.
Pageof 18